Legislative record

SB 2933STATE · HawaiiIn Committee

RELATING TO HEALTH CARE COSTS.

Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.

Voted 2/18/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

  1. 2/18/2026The committee on CPN deferred the measure.
  2. 2/18/2026The committee on HHS deferred the measure.
  3. 2/17/2026The committee(s) on HHS/CPN deferred the measure until 02-18-26 10:06AM; Conference Room 229 & Videoconference.
  4. 2/13/2026The committee(s) on HHS/CPN has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference.
  5. 1/30/2026Referred to HHS/CPN, WAM/JDC.
  6. 1/26/2026Passed First Reading.
  7. 1/23/2026Introduced.